Srinivas Aluri

932 total citations
30 papers, 291 citations indexed

About

Srinivas Aluri is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Srinivas Aluri has authored 30 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Hematology and 9 papers in Oncology. Recurrent topics in Srinivas Aluri's work include Acute Myeloid Leukemia Research (9 papers), Folate and B Vitamins Research (9 papers) and Drug Transport and Resistance Mechanisms (5 papers). Srinivas Aluri is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Folate and B Vitamins Research (9 papers) and Drug Transport and Resistance Mechanisms (5 papers). Srinivas Aluri collaborates with scholars based in United States, India and China. Srinivas Aluri's co-authors include Rongbao Zhao, I. David Goldman, Umesh Varshney, Amit Verma, Nishi Shah, Rami S. Komrokji, Rajasekhar N.V.S. Suragani, Tushar D. Bhagat, András Fiser and Mark J. Alexander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Srinivas Aluri

27 papers receiving 291 citations

Peers

Srinivas Aluri
Etsuko Aoki United States
Srinivas Aluri
Citations per year, relative to Srinivas Aluri Srinivas Aluri (= 1×) peers Etsuko Aoki

Countries citing papers authored by Srinivas Aluri

Since Specialization
Citations

This map shows the geographic impact of Srinivas Aluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Aluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Aluri more than expected).

Fields of papers citing papers by Srinivas Aluri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivas Aluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Aluri. The network helps show where Srinivas Aluri may publish in the future.

Co-authorship network of co-authors of Srinivas Aluri

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivas Aluri. A scholar is included among the top collaborators of Srinivas Aluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivas Aluri. Srinivas Aluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aluri, Srinivas, et al.. (2025). Metastatic Poorly Differentiated Carcinoma in a Patient With Crohn's Disease: A Case of Pulmonary-origin Cancer With Multisystem Involvement. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A4913–A4913.
2.
Aleman, Adolfo, Rongbao Zhao, Rahul Sanawar, et al.. (2024). BCMA CART Therapy Failure in Myeloma Is Associated with Immunosuppressive S100A8/9 Overexpression and Can be Ameliorated with Novel Monoclonal Antibodies. Blood. 144(Supplement 1). 589–589. 2 indexed citations
3.
Aluri, Srinivas, Aarif Ahsan, Sheida Hayati, et al.. (2023). P697: DISTINCT SPLICING ALTERATIONS ASSOCIATED WITH CLINICAL RESPONSE TO LUSPATERCEPT IN PATIENTS WITH LOWER‑RISK MYELODYSPLASTIC SYNDROMES FROM THE MEDALIST STUDY. HemaSphere. 7(S3). e8463948–e8463948. 1 indexed citations
4.
Aluri, Srinivas, Marc Ruíz-Martínez, Ashwin Sridharan, et al.. (2023). Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice. eLife. 12. 5 indexed citations
5.
Vegivinti, Charan Thej Reddy, Praneeth Reddy Keesari, Catarina Maia, et al.. (2023). Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review. Experimental Hematology and Oncology. 12(1). 60–60. 17 indexed citations
6.
Giricz, Orsi, Rachel Zeig‐Owens, Kith Pradhan, et al.. (2023). 2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.. Experimental Hematology. 124. S41–S41.
7.
Potts, Kathryn, Rosannah C. Cameron, Amina Metidji, et al.. (2022). Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition. Cell Reports. 41(11). 111825–111825. 4 indexed citations
8.
Aluri, Srinivas, et al.. (2022). Iron Chelation Improves Ineffective Erythropoiesis and Iron Overload in a Mouse Model of Myelodysplastic Syndrome. Blood. 140(Supplement 1). 2458–2459. 1 indexed citations
9.
Luchtel, Rebecca A., Venkata R. Machha, Alexander Tischer, et al.. (2021). Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer. Proceedings of the National Academy of Sciences. 118(39). 52 indexed citations
10.
Gordon, Shanisha, Srinivas Aluri, Yang Shi, et al.. (2021). A Transgenic Murine Model Expressing Hyperactive STAT3 Recapitulates the Features of MDS/AML. Blood. 138(Supplement 1). 3308–3308.
11.
Verma, Amit, Rajasekhar N.V.S. Suragani, Srinivas Aluri, et al.. (2020). Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes. Journal of Clinical Investigation. 130(2). 582–589. 45 indexed citations
12.
Aluri, Srinivas, et al.. (2020). A proton-coupled folate transporter mutation causing hereditary folate malabsorption locks the protein in an inward-open conformation. Journal of Biological Chemistry. 295(46). 15650–15661. 3 indexed citations
13.
Herrera, Diego Adrianzen, Gaurav S. Choudhary, Shanisha Gordon-Mitchell, et al.. (2020). The thrombopoietin mimetic JNJ-26366821 increases megakaryopoiesis without affecting malignant myeloid proliferation. Leukemia & lymphoma. 61(10). 2453–2465. 1 indexed citations
14.
Aluri, Srinivas, et al.. (2019). Substitutions that lock and unlock the proton-coupled folate transporter (PCFT-SLC46A1) in an inward-open conformation. Journal of Biological Chemistry. 294(18). 7245–7258. 5 indexed citations
15.
Zhao, Rongbao, et al.. (2018). Concentrative Transport of Antifolates Mediated by the Proton-Coupled Folate Transporter (SLC46A1); Augmentation by a HEPES Buffer. Molecular Pharmacology. 93(3). 208–215. 5 indexed citations
16.
Aluri, Srinivas, Rongbao Zhao, András Fiser, & I. David Goldman. (2017). Residues in the eighth transmembrane domain of the proton-coupled folate transporter (SLC46A1) play an important role in defining the aqueous translocation pathway and in folate substrate binding. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1859(11). 2193–2202. 8 indexed citations
17.
Zhao, Rongbao, et al.. (2017). Impact of posttranslational modifications of engineered cysteines on the substituted cysteine accessibility method: evidence for glutathionylation. American Journal of Physiology-Cell Physiology. 312(4). C517–C526. 6 indexed citations
18.
Aluri, Srinivas, et al.. (2017). Fidelity of translation in the presence of mammalian mitochondrial initiation factor 3. Mitochondrion. 39. 1–8. 10 indexed citations
19.
Zhao, Rongbao, Srinivas Aluri, & I. David Goldman. (2016). The proton-coupled folate transporter (PCFT-SLC46A1) and the syndrome of systemic and cerebral folate deficiency of infancy: Hereditary folate malabsorption. Molecular Aspects of Medicine. 53. 57–72. 56 indexed citations
20.
Aluri, Srinivas, et al.. (2015). Simultaneous presence offhsandpurTgenes is disadvantageous for the fitness ofEscherichia coligrowth. FEMS Microbiology Letters. 362(14). fnv101–fnv101. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026